ʻO Fmoc-MeIle-OH CAS:138775-22-1

Loaʻa iā Fmoc-MeIle-OH ka hoʻohana nui ʻana i ka kemika peptide, ka noiʻi lāʻau lapaʻau, a me ka biotechnology no ka hana ʻana i nā peptides me nā ʻano a me nā waiwai i hoʻololi ʻia. Ma ke ʻano he ʻāpana kumu i ka synthesis peptide solid-phase, hiki iā ia ke kūkulu ʻana i nā peptides me nā hoʻololi kikoʻī, e ʻae ana i nā mea noiʻi e noiʻi i ka hopena o N-methylation ma ke ʻano peptide, ka paʻa, a me ka bioactivity. Hoʻohana ʻia ʻo Fmoc-MeIle-OH i ka hoʻomohala ʻana i nā analog peptide, peptidomimetics, a me nā haʻawina pilina hana-hana e kālele ana i ka hoʻonui ʻana i nā moho lāʻau lapaʻau peptide-based. ʻO ke kiʻekiʻe o ka maʻemaʻe a me ke kūpaʻa o Fmoc-MeIle-OH e lilo ia i koho kūpono no ka hana ʻana i nā peptides me ka mana pololei ma luna o ka hoʻokomo ʻana o N-methyl isoleucine. ʻO kona kūlike me nā protocols synthesis peptide maʻamau a me nā reagents e hōʻoia i ka hoʻohui maʻalahi i nā kahe hana hale hana, e hoʻoikaika ana i nā ʻepekema e hana i nā peptides me nā ʻano a me nā hana i hana ʻia. Inā hoʻohana ʻia i ka noiʻi kula a i ʻole nā ​​​​noi ʻoihana, hāʻawi ʻo Fmoc-MeIle-OH i ka hoʻolaha ʻana i ke kahua o ka ʻike lāʻau lapaʻau peptide-based, ka noiʻi biomedical, a me ka hoʻomohala ʻana i nā therapeutics peptide hou no nā noi lapaʻau like ʻole.